H. Chalfin

发表

Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer.

K. Pienta, S. Glavaris, Michael H. Johnson, 2019, European urology oncology.

Robotic Primary RPLND for Stage I Testicular Cancer: a Review of Indications and Outcomes

P. Pierorazio, M. Allaf, W. Ludwig, 2016, Current Urology Reports.

MRI-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer.

P. Choyke, H. Parnes, M. Merino, 2020, The Journal of urology.

Patterns of Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy for Low-risk Men.

B. Trock, A. Partin, Zhaoyong Feng, 2017, Urology.

Improving Prostate Cancer Screening and Diagnosis: Health Policy and Biomarkers Beyond PSA.

H. Carter, H. Patel, H. Chalfin, 2016, JAMA oncology.

Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms

K. Pienta, P. Nelson, Jun Luo, 2018, The Journal of urology.

Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era.

Christopher L. Wu, P. Pierorazio, Michael H. Johnson, 2018, Urology.

Case Report: Fatal Complications of BK Virus-Hemorrhagic Cystitis and Severe Cytokine Release Syndrome Following BK Virus-Specific T-Cells

E. Levy, D. Kleiner, A. Freeman, 2021, Frontiers in Immunology.

Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer.

S. Steinberg, B. Turkbey, A. Civelek, 2021, Urologic oncology.

Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy.

Michael H. Johnson, M. Kates, T. Bivalacqua, 2017, Urologic oncology.

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

S. Steinberg, H. Parnes, J. Trepel, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

S. Steinberg, Yipeng Wang, J. Trepel, 2020, Clinical Cancer Research.

Focal therapy for prostate cancer: recent advances and future directions.

P. Pinto, Nitin K. Yerram, N. Nandanan, 2020, Clinical advances in hematology & oncology : H&O.

Impact of surgical margin status on prostate‐cancer‐specific mortality

B. Trock, A. Partin, P. Walsh, 2012, BJU international.

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

S. Steinberg, H. Parnes, M. Merino, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic versus autologous blood transfusion and survival after radical prostatectomy (CME)

B. Trock, A. Partin, C. Drake, 2014, Transfusion.

Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer

K. Pienta, L. Wood, T. D. de Reijke, 2018, The Prostate.

Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.

James E. Verdone, K. Pienta, S. Glavaris, 2017, Urology.

Variability in Medicare utilization and payment among urologists.

Misop Han, Kevin D Frick, Elizabeth Humphreys, 2015, Urology.

Characterization of the macrophage infiltrate in a case of xanthogranulomatous pyelonephritis

P. Pierorazio, M. Gorin, Jelani C. Zarif, 2018, Journal of clinical urology.

Selection‐free method reveals phenotypic diversity among prostate cancer circulating tumour cells

K. Pienta, M. Gorin, H. Chalfin, 2017, BJU international.

Role of biobanking in urology: a review

K. Pienta, A. Partin, L. Mangold, 2016, BJU international.

Nucleolin Staining May Aid in the Identification of Circulating Prostate Cancer Cells

K. Pienta, S. Glavaris, M. Gorin, 2017, Clinical genitourinary cancer.

The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality

B. Trock, A. Partin, J. Epstein, 2017, The Journal of urology.

Obesity and long-term survival after radical prostatectomy.

B. Trock, A. Partin, P. Walsh, 2014, The Journal of urology.

The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.

B. Trock, A. Partin, P. Walsh, 2015, European urology.

Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy

B. Trock, C. Drake, G. Netto, 2016, Annals of Surgical Oncology.

A novel multiplex score to predict outcomes of partial nephrectomy for multiple tumors.

Mark W. Ball, W. Linehan, Nitin K. Yerram, 2020, Urologic oncology.

New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.

B. Trock, A. Partin, J. Epstein, 2017, European urology.

Predicting the risk of non-organ-confined prostate cancer when perineural invasion is found on biopsy.

B. Trock, A. Partin, J. Epstein, 2014, Urology.

A novel multiplex score to predict outcomes of partial nephrectomy for multiple tumors.

Nitin K. Yerram, H. Chalfin, S. Gurram, 2023, Urologic oncology.